Purchase Order 75N93023P00060

The Department of Health and Human Services (HHS) National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $61,150.00 firm fixed price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, for SARS-COV-2 immunosequencing testing services. The contract has a performance period through September 30, 2024 and was awarded on May 7, 2024. Adaptive has previously provided specialized testing and genomic sequencing services to HHS,...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for $11,475 on November 2, 2020, for immunosequencing extraction services. Work is performed in Seattle, Washington. The order carries a firm fixed-price structure with an ultimate completion date of December 31, 2020. This award was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in...

Adaptive Biotechnologies Corporation has been awarded a firm fixed price purchase order valued at thirteen thousand two hundred dollars from the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. Under this contract, Adaptive will provide laboratory testing, adaptive immunosequencing, and DNA extraction services in support of unspecified NIH research programs. Performance will take place in Seattle, Washington through...

This $19,835 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation (Adaptive) for COVID-19 research and B-cell sequencing services. The contract has a period of performance through March 24, 2021. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts and...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Adaptive Biotechnologies Corporation ("Adaptive") for immunosequencing extraction services. The $12,750 contract was awarded on December 10, 2019 with a completion date of December 10, 2020. Adaptive is a commercial provider of immune-driven medicine services and products. The company has...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,690 firm fixed-price purchase order to Adaptive Biotechnologies Corporation (doing business as Adaptive) for ImmunoSEQ sequencing services. The contract has an ultimate completion date of December 20, 2024. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts and grants from the Department of Health and Human Services (HHS), Department...

This is a $12,300 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation (Adaptive) for "IMMUNOSEQ MMTCRB SEQUENCING SERVICE". The contract has an ultimate completion date of December 31, 2023 and was awarded on September 19, 2023 without a set-aside designation. Adaptive, a for-profit organization, has previously...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation valued at $16,800 on September 6, 2017, with an ultimate completion date of September 14, 2017. Place of performance is Seattle, Washington. The order is for firm fixed-price immunosequencing services. No set-aside category applies.</p>

Adaptive Biotechnologies Corporation, doing business as Adaptive, has been awarded a firm fixed price purchase order valued at thirteen thousand four hundred dollars from the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. Under this contract, Adaptive will provide immunosequencing and laboratory testing services in support of the agency's research programs. Specifically, Adaptive will deliver T-cell receptor beta...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for immunosequencing services (ImmunoSEQ MMTCRB sequencing) valued at $12,200.00, with award and completion dates of July 12, 2018 and July 12, 2019 respectively.</p> <p>Performance occurs in Seattle, Washington. The order is firm fixed price with no set-aside designation.</p>